glp-1 compounding crackdown news october 2025 Non-Traditional Channels: The Compounded Market FDA Demurs on GLP-1 Compounding

Pricing Breakdown Sheds pricing varies by medication format

The future of GLP-1 probiotics and microbiome-based metabolic medicine Pendulum GLP-1 Probiotic Pro represents an early entry in what many researchers believe will become a major category of metabolic therapeutics

In 2024, 95% of adverse events associated with GLP-1s were related to either how the product was dosed or how it was administered, rather than issues with the drug

2025 Feb;85(2):196-204.e1

This pronounced transformation in dietary preferences and spending behaviors is prompting food manufacturers to shift their marketing strategy and adapt their product offerings